Gene Polymorphism of Xenobiotic Biotransformation Enzymes in Patients with Classical Ph-Negative Myeloproliferative Neoplasms
- 作者: Ovsepyan V.A.1, Tregubova E.V.1, Luchinin A.S.1, Minaeva N.V.1
-
隶属关系:
- Kirov Research Institute of Hematology and Blood Transfusion, Federal Medical and Biological Agency of the Russian Federation
- 期: 卷 167, 编号 6 (2019)
- 页面: 767-770
- 栏目: Genetics
- URL: https://journal-vniispk.ru/0007-4888/article/view/242105
- DOI: https://doi.org/10.1007/s10517-019-04619-5
- ID: 242105
如何引用文章
详细
The correlation of gene polymorphisms rs4025935 (large deletion), rs1695 (313A>G), rs71748309 (large deletion), and rs1800566 (609C>T) of GSTM1, GSTT1, and NQO1 genes encoding glutathione-S-transferases (GST) M1, P1, and T1 and NADPH-quinone oxidoreductase with the risk of development of classical Ph-negative myeloproliferative neoplasms (polycythemia vera, essential thrombocythemia, and primary myelofibrosis) was studied in the Caucasian ethnicity population of Vyatka region of the Russian Federation. It was found that NQO1*609T allele, NQO1*609T genotypes, and homozygous carriage of a deletion (null) allele of GSTT1 gene are associated with the risk of development of myeloproliferative neoplasms (OR=1.29, 95%CI=1.02-1.64, p=0.04; OR=1.39, 95%CI=1.04-1.85, p=0.03; and OR=1.48, 95%CI=1.03-2.12, p=0.03, respectively). However, no influence of GSTM1 and GSTP1 gene polymorphisms on the risk of development of myeloproliferative disorders was registered.
作者简介
V. Ovsepyan
Kirov Research Institute of Hematology and Blood Transfusion, Federal Medical and Biological Agency of the Russian Federation
编辑信件的主要联系方式.
Email: vovsepyan@mail.ru
俄罗斯联邦, Kirov
E. Tregubova
Kirov Research Institute of Hematology and Blood Transfusion, Federal Medical and Biological Agency of the Russian Federation
Email: vovsepyan@mail.ru
俄罗斯联邦, Kirov
A. Luchinin
Kirov Research Institute of Hematology and Blood Transfusion, Federal Medical and Biological Agency of the Russian Federation
Email: vovsepyan@mail.ru
俄罗斯联邦, Kirov
N. Minaeva
Kirov Research Institute of Hematology and Blood Transfusion, Federal Medical and Biological Agency of the Russian Federation
Email: vovsepyan@mail.ru
俄罗斯联邦, Kirov
补充文件
